Oncology recruiting and talent strategy.
Oncology devices and diagnostics sit inside a service line measured on referral volume and adherence to treatment pathways. Decisions run through tumor boards, pharmacy and value analysis rather than a single surgeon, and every product carries a clinical burden of proof and a reimbursement argument. Clinical research, medical affairs, engineering, regulatory and commercial teams all compete for the same patient against medical and surgical options.
- MedTech only, since 2001
- 25+ yearsMedTech only, since 2001
- Placements made
- 3,500+Placements made
- We search, listed below
- 7 areasWe search, listed below
Inside oncology.
A search usually sits in one of these areas, and often spans two or three.
Surgical oncology
Tumor resection across general surgery, thoracic, GI, gynecologic and urologic services, with the devices that support margin control, staging and reconstruction. Imaging and margin assessment technology, clinical evidence and case support all have to survive tumor board and value analysis review.
- Imaging Scientist
- Clinical Research Manager
- Clinical Specialist
- Territory Manager
Interventional oncology
Catheter and needle-based cancer treatment delivered in a procedural suite, including transarterial chemoembolization, radioembolization and percutaneous ablation. Growth depends on clinical data and on whether medical and surgical oncology send patients, so medical affairs and engineering matter alongside referral development.
- R&D Engineer
- Medical Science Liaison
- Clinical Specialist
- Therapy Development Manager
Cancer diagnostics
Tissue, liquid biopsy and molecular testing that decides whether a patient is treated and with what. Buyers are pathologists, lab directors and payers, so assay development, bioinformatics, laboratory operations and coverage work drive the business.
- Assay Development Scientist
- Bioinformatics Scientist
- Market Access Manager
- Clinical Account Manager
Oncology navigation and delivery
Patient navigation, infusion scheduling, symptom monitoring and the systems that hold a cancer program's throughput together. The buyer is the service line administrator, so software engineering, clinical informatics and implementation are at the center of the deal.
- Software Engineer
- Clinical Informatics Specialist
- Clinical Implementation Specialist
- Strategic Account Manager
Neuro-oncology
Primary brain tumors and metastatic disease, where surgical resection, radiation and device-based therapy are sequenced by a small group of physicians at a limited number of centers. Volumes per site are low, so clinical trial work, field engineering and account depth matter more than call frequency.
- Clinical Trial Manager
- Field Clinical Engineer
- Medical Science Liaison
- Territory Business Manager
Tumor treating and energy-based therapy
Therapies that treat tumors with applied energy fields, heat, cold or electrical pulses rather than resection or a drug. Uptake is slowed by reimbursement and physician skepticism about the evidence, so engineering, clinical studies and coverage work carry the category.
- Biomedical Engineer
- Clinical Affairs Director
- Reimbursement Manager
- Clinical Applications Specialist
Supportive care
Vascular access, nutrition, wound and symptom management products that surround treatment without being the treatment. Purchasing is contracted and price-sensitive, so manufacturing cost, quality and reliable supply hold share alongside education and in-service support.
- Quality Engineer
- Supply Chain Manager
- Clinical Educator
- National Accounts Manager
Where oncology searches go wrong.
The assumptions that cost the most time, and what tends to be true instead.
“A cancer center decision closes like a surgical sale”
Cancer programs buy against a treatment pathway, so the decision involves medical oncology, the tumor board and often pharmacy, and it moves on the committee calendar rather than one surgeon's preference. Hiring for this means testing whether a candidate can build consensus over months and hold an account through a pathway revision, not only whether they can close.
“Oncology R&D and clinical hires must come from the same tumor type”
Tumor type knowledge is learnable. What transfers is experience generating evidence that changes a pathway: trial design, endpoints a tumor board accepts and data payers will cover. Scientists and clinical leaders who have done that in any cancer indication tend to ramp faster than specialists who know the histology but have never moved a guideline.
“Diagnostics and devices can share one leadership team”
Diagnostic revenue is paid through the lab budget or a payer contract and depends on laboratory operations and coverage. Device revenue is paid through the procedure and depends on engineering and case support. Leaders who run both as one business usually invest in one and report on the other. Separate leadership and separate hiring profiles hold up better.
“The ideal candidate already holds this exact title, at this kind of company, in this therapeutic area, and will take it for less than they earn now.”
The best markers are whether someone has repeatedly sold into the same call points, navigated a complex sale and its failures, built a territory, launched new technology, or can point to real examples of building champions for a product. Then listen for ownership: candidates who talk in I, me and my rather than passing the blame to they, them and theirs.
Zach Mathews, Talent Advisor
Individual contributors to executive leadership.
The same vertical knowledge applies across commercial, clinical, R&D and engineering, regulatory, quality and operations, whether the seat is in the field, the lab, the plant or the boardroom.
- Executive
- Sales
- Marketing
- Clinical
- Regulatory
- Quality
- R&D
- Engineering
- Operations
- National Accounts
- Market Access
Four steps, every time.
The same sequence whether the seat is an engineer, a clinical lead or a territory in oncology, or the executive who builds the team around them.
- 01Define
A Talent Director who knows your specialty scopes the role, what it has to deliver and the profile that actually wins in your market.
- 02Search & vet
We reach passive candidates others can't, then screen for skill, culture fit and motivation before you see a single resume.
- 03Present
Three to five qualified, interested candidates with our written assessment. Interviews are coordinated for you.
- 04Close & onboard
Offer strategy, counter-offer prep and a 90-day check-in so great hires become long-term ones.
Two ways to work with us in oncology.
Next door to this vertical.
- How MedTech leaders position themselves for the next level of leadershipZach Mathews
- Building a relationship network before you need your next executive roleZach Mathews
- How hiring managers should evaluate transferable medical device sales experienceZach Mathews
- Identifying the right commercial profile for an emerging or growth-stage MedTech companyZach Mathews
- Helping high-performing individual contributors become effective leadersZach Mathews
Filling seats isn't the objective. The business outcome is.
Tell us what this hire needs to make possible.
We'll bring you the oncology market before we bring you a shortlist.